Press Releases

This email address is being protected from spambots. You need JavaScript enabled to view it.
Sun - Fri 8:00 - 20:30

The 'Press Releases' section offers the latest product-specific and company-related updates to our esteemed clients, providing them with a valuable resource. Members can leverage this platform for quick, efficient, and effective visibility.

— Our press release programs complement our content distribution initiatives, ensuring strong positioning across major media outlets and social media channels. This enhances the visibility of your message within the global pharmaceutical industry.

Harrow Announces Availability of Fortisite™ Formulations for In-Office Use

Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, the availability, for in-office use, of Fortisite™ (compounded Tobramycin 1.5% + Vancomycin 5%) from its FDA‑registered and FDA‑inspected ImprimisRx® 503B outsourcing facility.

Collink.3D 50L, rhCollagen-based bioink in a powder form

CollPlant Enriches Portfolio of rhCollagen

CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing.

Latest Press Releases

Harrow Announces Availability of Fortisite™ Formulations for In-Office Use

CollPlant Enriches Portfolio of rhCollagen

Account Center

Useful Links

Top White Papers

Subscriber's Hub